| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 13, 2023 | RMD Resmed Inc | Ghoshal Kaushik64 | President, Saas Business | Sell | 500 | $220.00 | $110,000.00 | -4.1% | -34.0% | -6.3% | |
| Jul 12, 2023 | ICUI Icu Medical Inc/de | Jain Vivek83 | Chairman And CEO | Sell | 30,000 | $180.02 | $5,400,720.00 | -55.9% | -33.6% | -28.6% | |
| Jul 12, 2023 | ELMD Electromed, Inc. | Skarvan Kathleen71 | Director | Sell | 1,107 | $10.83 | $11,991.58 | -0.8% | -4.1% | +32.1% | |
| Jul 12, 2023 | GKOS Glaukos Corp | Gilliam Joseph E55 | President &COO | Sell | 2,700 | $73.09 | $197,343.00 | -2.2% | +0.7% | +71.2% | |
| Jul 12, 2023 | IRMD Iradimed Corp | Susi Roger E.53 | CEO, President, Chairman | Sell | 10,000 | $46.35 | $463,480.37 | -1.2% | -13.0% | +0.1% | |
| Jul 12, 2023 | MXCT Maxcyte, Inc. | Doerfler Douglas81 | President And CEO | Sell | 30,000 | $5.03 | $150,851.51 | -2.9% | -38.8% | -10.8% | |
| Jul 11, 2023 | PEN Penumbra Inc | Elsesser Adam62 | CEO And President | Sell | 9,666 | $322.98 | $3,121,955.78 | -36.9% | -30.6% | -44.2% | |
| Jul 11, 2023 | BLFS Biolife Solutions Inc | Schulz Marcus71 | Chief Revenue Officer | Sell | 331 | $22.79 | $7,543.49 | -0.8% | -42.0% | -15.9% | |
| Jul 11, 2023 | STIM Neuronetics, Inc. | MacAn William Andrew66 | EVP, GC, CCO And Cs | Sell | 2,645 | $2.13 | $5,633.85 | -0.7% | -46.8% | -14.4% | |
| Jul 10, 2023 | DXCM Dexcom Inc | Stern Sadie72 | EVP Chief Human Resources Offi | Sell | 392 | $128.05 | $50,195.60 | -0.5% | -36.4% | -15.1% | |
| Jul 10, 2023 | INSP Inspire Medical Systems, Inc. | Griffin Jerry C84 | Director | Sell | 529 | $310.42 | $164,212.18 | -3.3% | -43.2% | -57.7% | |
| Jul 10, 2023 | DXCM Dexcom Inc | Regan Barry J.60 | EVP Operations | Sell | 1,989 | $128.05 | $254,691.45 | -2.9% | -36.4% | -15.1% | |
| Jul 10, 2023 | MDT Medtronic Plc | Ten Hoedt Rob61 | EVP And Pres. Global Regions | Sell | 5,514 | $86.58 | $477,420.20 | -5.9% | -13.1% | -11.1% | |
| Jul 10, 2023 | GKOS Glaukos Corp | Burns Thomas William | Chairman &CEO | Sell | 13,573 | $70.86 | $961,790.13 | -0.7% | +1.4% | +72.1% | |
| Jul 10, 2023 | EW Edwards Lifesciences Corp | Szyman Catherine M.67 | Cvp, Critical Care | Sell | 5,000 | $90.52 | $452,600.00 | -12.6% | -20.4% | +2.0% | |
| Jul 7, 2023 | CTKB Cytek Biosciences, Inc. | Jiang Wenbin75 | President And CEO | Sell | 20,000 | $8.48 | $169,600.00 | -0.3% | -35.9% | -34.0% | |
| Jul 6, 2023 | IRMD Iradimed Corp | Susi Roger E.53 | CEO, President, Chairman | Sell | 10,000 | $45.86 | $458,612.90 | -1.2% | -6.6% | -4.3% | |
| Jul 5, 2023 | BFLY Butterfly Network, Inc. | Weiss Lawrence T69 | CLO, GC And Corp Sec | Sell | 27,655 | $2.19 | $60,509.14 | -2.2% | -51.6% | -54.6% | |
| Jul 5, 2023 | EW Edwards Lifesciences Corp | Mussallem Michael A65 | Director | Sell | 29,350 | $90.78 | $2,664,487.48 | -18.4% | -23.5% | +1.5% | |
| Jul 5, 2023 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 4,859 | $1.83 | $8,877.39 | -0.8% | -72.0% | -87.1% | |
| Jul 5, 2023 | BFLY Butterfly Network, Inc. | Getz Heather C52 | EVP &Chief Financial Officer | Sell | 65,577 | $2.19 | $143,482.48 | -4.5% | -51.6% | -54.6% | |
| Jul 5, 2023 | BFLY Butterfly Network, Inc. | Stoica Andrei G53 | Chief Technology Officer | Sell | 47,320 | $2.19 | $103,785.84 | -2.2% | -51.6% | -54.6% | |
| Jul 5, 2023 | GKOS Glaukos Corp | Burns Thomas William | Chairman &CEO | Sell | 31,427 | $69.59 | $2,187,031.24 | -1.5% | +2.4% | +74.8% | |
| Jul 5, 2023 | LFWD Lifeward Ltd. | Lind Global Fund II LP51 | - | Buy | 83,479 | $0.69 | $57,582.71 | +0.9% | -6.3% | -32.1% | |
| Jul 3, 2023 | PEN Penumbra Inc | Roberts Johanna54 | EVP, Gen. Counsel &Secretary | Sell | 900 | $340.18 | $306,162.19 | -0.3% | -29.6% | -48.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.